Skip to main content

Journey Medical Corp

DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867066

No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Journey Medical Corp changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of DERM: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders35236+3
Shares2.36M63.5K2.16M−139.8K (−6.1%)
Value$13.3M$358.0K$12.2M−$765.9K (−5.9%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Journey Medical Corp at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DERM in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.52,618$297.3K0.00%
ORG Wealth Partners, LLC19,519$110.3K0.04%
Titleist Asset Management, LLC14,250$80.5K0.01%
Kovitz Investment Group Partners, LLC11,605$65.6K0.00%
Nwam LLC10,430$58.9K0.00%
Wealthcare Capital Management LLC10,000$56.5K0.01%
Private Trust Co NA500$2.83K0.00%

Sold out (4)

Institutions that held Journey Medical Corp at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DERM in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Tang Capital Management LLC148,322$836.5K
Royce & Associates LP12,654$71.4K
Virtu Financial LLC10,542$59.0K
Transcendent Capital Group LLC500$2.82K

Not filed for Q3 2024 yet (2)

Institutions that held Journey Medical Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DERM in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.51,864$292.5K
TMD Wealth Management, LLC11,605$65.5K